University of East Anglia researchers have discovered the genetic blueprints of 18 new bacterial species collected from prostate cancer patients.
Researchers at the University of Colorado Anschutz have discovered how herpes simplex virus type 1 (HSV-1), the virus that causes cold sores, can fundamentally change how the brain’s immune cells respond to infection, revealing a potentially important connection between viral infection, chronic inflammation and Alzheimer’s disease.
A new study in the IEEE Journal of Biomedical and Health Informatics reveals how scientists at Klick Labs created visual maps of sound frequencies (spectrograms) to identify complex, new patterns associated with type 2 diabetes, using only smartphone recordings of randomly selected short English sentences and participant sex as study criteria.
An international research team led by IMDEA Materials Institute and Universidad Politécnica de Madrid (UPM) has developed a method for manufacturing personalized cardiovascular medical devices using three-dimensional printing of nitinol, a superelastic alloy.
Results from a Phase I clinical trial led by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) show a possible way to improve therapy options for patients with relapsed or treatment-resistant B-cell blood cancers. The findings are published in Blood Cancer Discovery.
A new artificial intelligence tool developed by Northwestern Medicine scientists and collaborating institutions can help determine whether genetic variants associated with a severe form of childhood epilepsy will cause disease, according to a study published in the Journal of Clinical Investigation.
Learn how mRNA and its lipid packaging change in the bloodstream, offering insights that could help researchers design better vaccines and future cancer therapies.
An AI system trained on photographs of the face and tongue correctly identified every patient with coronary heart disease (CHD) in a small test, according to a new study from China.
Why do some prostate cancers grow slowly for years, while others progress quickly to life-threatening metastatic disease? An international team of researchers co-led by the Ontario Institute for Cancer Research (OICR) and the University of Copenhagen has uncovered new clues in the genomes of prostate cancers.
Researchers were able to restore the function of neurons linked to cognitive function and information processing in mice that mimic key features of Alzheimer’s disease, showing early promise for the development of a similar targeted therapy in humans. The findings are published in Neuron.